-
Product Insights
Cerritos Clg – Norwalk Student Services and Administration Building – California
The Cerritos Clg – Norwalk Student Services and Administration Building – California involves the construction of a 10,962m2 new student services and administration building in Norwalk, California, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Cerritos Clg – Norwalk Student Services and Administration Building – California report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of...
-
Product Insights
Australian Gov/ Fraser Coast – Hervey Bay Library and Fraser Coast Regional Council Administration Center – Queensland
The Australian Gov/ Fraser Coast – Hervey Bay Library and Fraser Coast Regional Council Administration Center – Queensland involves the construction of an administration center and a two-story library in Pialba, NSW, Australia. Equip yourself with the essential tools needed to make informed and profitable decisions with our Australian Gov/ Fraser Coast – Hervey Bay Library and Fraser Coast Regional Council Administration Center – Queensland report. Note: This is an on-demand report that will be delivered upon request. The report...
-
Product Insights
New Administrative Capital Substation
Empower your strategies with our New Administrative Capital Substation report and make more profitable business decisions. New Administrative Capital Substation is under construction at New Administrative Capital, Cairo, Egypt./p> New Administrative Capital Substation project profile includes core details such as project name, technology, voltage, status, plant proponents (owners, system operator etc.), as well as key operational data including year online, voltage level, investment etc. Details on project specific contacts along with relevant news, deals and contracts are also provided through...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD) Drug...
-
Product Insights
NewAlpha Galactosidase A – Drugs In Development, 2024
The Alpha Galactosidase A pipeline drugs market research report outlays comprehensive information on the Alpha Galactosidase A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Fabry Disease. It also reviews key players involved in Alpha Galactosidase A targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...
-
Product Insights
NewGalactocerebrosidase – Drugs In Development, 2024
The Galactocerebrosidase pipeline drugs market research report outlays comprehensive information on the Galactocerebrosidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System which include indications of Globoid Cell Leukodystrophy (Krabbe Disease). It also reviews key players involved in Galactocerebrosidase targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is an...
-
Product Insights
NewPoly – Drugs In Development, 2024
The Poly pipeline drugs market research report outlays comprehensive information on the Poly targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Solid Tumor. It also reviews key players involved in Poly targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is an “on-demand” report...
-
Product Insights
NewCD276 Antigen – Drugs In Development, 2024
The CD276 Antigen pipeline drugs market research report outlays comprehensive information on the CD276 Antigen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Unspecified Cancer. It also reviews key players involved in CD276 Antigen targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewPoliovirus Receptor – Drugs In Development, 2024
The Poliovirus Receptor pipeline drugs market research report outlays comprehensive information on the Poliovirus Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Solid Tumor. It also reviews key players involved in Poliovirus Receptor targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...